Lenalidomide and Eltrombopag for Treatment in Low or Intermediate Risk Myelodysplastic Syndrome: Result of a Phase 2 Study Combination Clinical Trial

Authors

Mohammad Hossein Kazemi MD, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

11-2021

Volume

138

Issue

1

Published In/Presented At

10.1182/blood-2021-146597

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine, Lehigh Valley Topper Cancer Institute

Document Type

Article